Amneal to Virtually Participate at the Morgan Stanley Global Healthcare Conference
September 01 2020 - 8:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today
announced that members of management will participate at the Morgan
Stanley Global Healthcare Conference held on September 15, 2020.
The presentation will begin at 4:15 PM Eastern Time and a live
webcast will be accessible through the Investor Relations section
of the Company's website at https://investors.amneal.com. A replay
of the webcast will be posted shortly after the call and will be
available for 90 days following the event.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is a fully-integrated pharmaceutical company
focused on the development, manufacturing and distribution of
generic and specialty drug products. The Company has operations in
North America, Asia, and Europe, working together to bring
high-quality medicines to patients primarily within the United
States.
Amneal has an extensive portfolio of approximately 250 product
families and is expanding its portfolio to include complex dosage
forms, including biosimilars, in a broad range of therapeutic
areas. The Company also markets a portfolio of branded
pharmaceutical products through its Specialty segment focused
principally on central nervous system and endocrine disorders.
The Company also owns 65% of AvKARE. AvKARE provides
pharmaceuticals, medical and surgical products and services
primarily to governmental agencies, primarily focused on serving
the Department of Defense and the Department of Veterans Affairs.
AvKARE is also a packager and wholesale distributor of
pharmaceuticals and vitamins to its retail and institutional
customers who are located throughout the United States focused
primarily on offering 340b-qualified entities products to provide
consistency in care and pricing. For more information, visit
www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200901005395/en/
Tasos Konidaris EVP, Chief Financial Officer
invest@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Sep 2023 to Sep 2024